Redox active agents in inflammatory lung injury.
James D
JD
Crapo
D000818:Animals; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects; D001761:Bleomycin / Q000009:adverse effects / Q000037:antagonists & inhibitors*; D018925:Chemokines / Q000235:genetics / Q000378:metabolism; D002633:Chemotaxis / Q000187:drug effects; D004195:Disease Models, Animal; D005260:Female; D020382:Interleukin-18 / Q000009:adverse effects / Q000037:antagonists & inhibitors* / Q000235:genetics; D007376:Interleukin-2 / Q000009:adverse effects / Q000037:antagonists & inhibitors* / Q000235:genetics; D017563:Lung Diseases, Interstitial / Q000209:etiology / Q000473:pathology / Q000517:prevention & control*; D051379:Mice; D008810:Mice, Inbred C57BL; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology; D013879:Thioredoxins / Q000494:pharmacology*
D000964:Antimetabolites, Antineoplastic; D018925:Chemokines; D020382:Interleukin-18; D007376:Interleukin-2; D001761:Bleomycin; D013879:Thioredoxins